Sales rise 19.89% to Rs 15.13 crore
Net Loss of Oxygenta Pharmaceutical reported to Rs 6.11 crore in the quarter ended June 2025 as against net loss of Rs 1.36 crore during the previous quarter ended June 2024. Sales rose 19.89% to Rs 15.13 crore in the quarter ended June 2025 as against Rs 12.62 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales15.1312.62 20 OPM %-45.14-14.03 -PBDT-7.29-2.16 -238 PBT-8.14-2.81 -190 NP-6.11-1.36 -349Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
